Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
40.97 BRL | -1.13% |
|
-1.32% | +78.44% |
Jun. 26 | Monetary policy is getting even more confusing | ![]() |
Jun. 26 | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- SRPT Stock
- S1RP34 Stock
- News Sarepta Therapeutics, Inc.
- Official Publications